MetLife Investment Advisors »

Forte Biosciences shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Forte Biosciences (FBRX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Forte Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Forte Biosciences held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Forte Biosciences by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $244k 12k 21.25

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class A Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Inc Class C Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Inc Class A Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm Bond (BSV)

View all positions for MetLife Investment Advisors

Top funds holding Forte Biosciences

Federated Investors
OrbiMed Advisors
Fred Alger Management
Jupiter Topco
BlackRock
Henderson Group
Affinity Asset Advisors
MPM Oncology Impact Management
TCG Crossover Management
Vanguard Capital Management
Woodline Partners
Adage Capital Partners GP
Integral Health Asset Management
Millennium Management
Citadel Advisors

View all funds holding Forte Biosciences